Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR^WT, EGFR^T790M, and EGFR^L858R)

Mahmoud G. Abo Al-Hamda Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, EgyptCorrespondence[email protected]
View further author information

Haytham O. Tawfika Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, EgyptCorrespondence[email protected]

Omeima Abdullahb Pharmaceutical Chemistry Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi ArabiaView further author information

Koki Yamaguchic Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, JapanView further author information

Masaharu Sugiurac Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, JapanView further author information

Ahmed B. M. Mehanyd Zoology Department, Faculty of Science, Al-Azhar University, Cairo, EgyptView further author information

Mervat H. El-Hamamsya Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, EgyptView further author information

Tarek F. El-Moselhya Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, EgyptView further author information

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.